Chronic Total Occlusion

Top Story

CTO PCI similar to medical therapy in CV death, MI risk at 3 years: EURO-CTO

CTO PCI similar to medical therapy in CV death, MI risk at 3 years: EURO-CTO
October 3, 2019
5 Questions with Dr. Bhatt

A Conversation With Emmanouil S. Brilakis, MD, PhD, FSCAI

Cardiology Today's Intervention, May/June 2019
For this issue, Dr. Bhatt talks with Cardiology Today’s Intervention Editorial Board Member Emmanouil S. Brilakis, MD, PhD, FSCAI, director of the Center for…
CTO Corner

Hiking and CTO PCI: Lessons Learned

Cardiology Today's Intervention, March/April 2019
Emmanouil S. Brilakis, MD, PhD
One might not think there are many similarities between hiking and chronic total occlusion PCI, but a recent family trip led me to think there are many lessons about…
FDA News

FDA approves stent platform to treat chronic total occlusions

February 26, 2019
Medtronic announced today that the FDA has approved its drug-eluting stent platform for treatment of de novo chronic total occlusion lesions in patients with CAD. The…
More Headlines »
CTO Corner

Risks, Benefits of CTO PCI Must be Weighed

Cardiology Today's Intervention, May/June 2017
Emmanouil S. Brilakis, MD, PhD
New data from the DECISION-CTO trial, presented at the American College of Cardiology Scientific Session in March, have…
More »
Video
Meeting News Coverage

VIDEO: Emmanouil S. Brilakis, MD, PhD, highlights new approaches in CTO PCI

October 30, 2015
More »
CTO Corner

A Challenging Case of Failed CTO PCI: Was It Worth It?

Cardiology Today's Intervention, March/April 2018
Emmanouil S. Brilakis, MD, PhD
It was 9 p.m. when the case ended. It was a 3-hour chronic total occlusion attempt that failed, fortunately without any…
More »